UB Paderborn / Katalog / Suche / in CDI

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2 Sudanese patients

Pharmacy practice : official journal of the GRIPP (Global Research Institute of Pharmacy Practice), 2018-10, Vol.16 (4), p.1274

2018

Volltextzugriff (PDF)

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2

Pharmacy practice, 2018-10, Vol.16 (4), p.1274-1274

2018

Volltextzugriff (PDF)

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2 Sudanese patients

Pharmacy practice : official journal of the GRIPP (Global Research Institute of Pharmacy Practice), 2018, Vol.16 (4), p.12-19

2018

Volltextzugriff (PDF)

Thermal Performance of Housing Open Spaces in the City of Mosul

Tikrit journal of engineering sciences, 2012-03, Vol.19 (1), p.13-24

2012

Volltextzugriff (PDF)

Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement

American journal of respiratory and critical care medicine, 2020-10, Vol.202 (7), p.e95-e112

2020

Volltextzugriff (PDF)

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2020-07, Vol.202 (2), p.e5-e31

2020

Volltextzugriff (PDF)

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial

The lancet oncology, 2021-11, Vol.22 (11), p.1597-1608

2021

Volltextzugriff (PDF)

Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective

Mayo Clinic proceedings, 2024-01, Vol.99 (1), p.15-21

2024

Volltextzugriff (PDF)

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Journal of clinical oncology, 2021-01, Vol.39 (1), p.57-65

2021

Volltextzugriff (PDF)

Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement

American journal of respiratory and critical care medicine, 2018-07, Vol.198 (2), p.e3-e13

2018

Volltextzugriff (PDF)

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials

Blood advances, 2024-05, Vol.8 (10), p.2509-2519

2024

Volltextzugriff (PDF)

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Leukemia, 2020-12, Vol.34 (12), p.3149-3160

2020

Volltextzugriff (PDF)

Photoacids as singlet oxygen photosensitizers: Direct determination of the excited state acidity by time-resolved spectroscopy

Journal of photochemistry and photobiology. A, Chemistry., 2018-09, Vol.364, p.819-825

2018

Volltextzugriff (PDF)

Physical‐layer security enhancement in wireless sensor networks through artificial noise optimization

Security and privacy, 2024-07, Vol.7 (4), p.n/a

2024

Volltextzugriff (PDF)

1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities

Bioorganic chemistry, 2019-03, Vol.84, p.150-163

2019

Volltextzugriff (PDF)

Estimation of CO2 emission factor for the energy industry sector in libya: a case study

Environment, development and sustainability, 2021-09, Vol.23 (9), p.13998-14026

2021

Volltextzugriff (PDF)

The impact of FDI on income inequality in Egypt

Economic change and restructuring, 2022-08, Vol.55 (3), p.2011-2030

2022

Volltextzugriff (PDF)

Do You Have To Evaluate The Heart Of The Cirrhotic Patients?

Journal of the Pakistan Medical Association, 2023-04, Vol.73(Suppl 4) (4), p.S221-S227

2023

Volltextzugriff (PDF)

Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors: a cross-sectional study

The Pan African medical journal, 2022-01, Vol.41, p.311-311

2022

Volltextzugriff (PDF)

Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23 (9), p.674-686

2023

Volltextzugriff (PDF)

Cross-cultural adaptation and reliability of the Arabic version of Children’s Hand-use Experience Questionnaire (CHEQ)

Hong Kong journal of occupational therapy, 2022-06, Vol.35 (1), p.84-95

2022

Volltextzugriff (PDF)

Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS7079-TPS7079

2023

Volltextzugriff (PDF)

Reliable Delay Based Algorithm to Boost PUF Security Against Modeling Attacks

Information (Basel), 2018-09, Vol.9 (9), p.224

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2 Sudanese patients

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2

Influence of self-efficacy management on adherence to self-care activities and treatment outcome among diabetes mellitus type 2 Sudanese patients

Thermal Performance of Housing Open Spaces in the City of Mosul

Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial

Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Photoacids as singlet oxygen photosensitizers: Direct determination of the excited state acidity by time-resolved spectroscopy

Physical‐layer security enhancement in wireless sensor networks through artificial noise optimization

1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities

Estimation of CO2 emission factor for the energy industry sector in libya: a case study

The impact of FDI on income inequality in Egypt

Do You Have To Evaluate The Heart Of The Cirrhotic Patients?

Irritable bowel syndrome in Egyptian medical students, prevalence and associated factors: a cross-sectional study

Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies

Cross-cultural adaptation and reliability of the Arabic version of Children’s Hand-use Experience Questionnaire (CHEQ)

Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia

Reliable Delay Based Algorithm to Boost PUF Security Against Modeling Attacks

Suchergebnisse filtern